fig1

Figure 1. Molecular classification of extrahepatic cholangiocarcinoma.Tumor and microenvironment molecular features of transcriptome-based Metabolic, Proliferation, Mesenchymal and Immune classes discovered in eCCA^[38]. Candidate targeted therapies with a potential benefit in Proliferation and Immune classes are proposed. Figure adapted from Montal et al. J. Hepatol 2020^[38].